Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Methyl bromoacetate → 4-Phenyl-4-((1-(3,5-bis(trifluoromethyl)phenyl)-2-methoxycarbonylmethoxy ethoxy)methyl)piperidine Hydrochloride
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Methyl bromoacetate | HCID 60984 | — |
| 반응물 | 4-Phenyl-4-((1-(3,5-bis(trifluoromethyl)phenyl)-2-hydroxyethoxy) methyl)piperidine Hydrochloride | HCID 19084700 | — |
| 생성물 | 4-Phenyl-4-((1-(3,5-bis(trifluoromethyl)phenyl)-2-methoxycarbonylmethoxy ethoxy)methyl)piperidine Hydrochloride | HCID 19084710 | — |
반응 단계
This was prepared in a similar manner as Example 2 using the compound of Example 1 (d) and methyl bromoacetate. 1H NMR (360 MHz, d6 -DMSO) δ7.98 (1H, s), 7.75 (2H, s), 7.41-7.24 (5H, m), 4.68 (1H, t, J=5 Hz), 4.11 (2H, s), 3.62 (3H, s), 3.69-3.30 (4H, m), 3.29-3.10 (2H, m), 2.78-2.60 (2H, m), 2.39-2.00 (4H, m). MS (Cl+) 520 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05760018 |
| 출처 데이터셋 | uspto-grants-1998_06 |
| ORD ID | ord-f3f52798b3804666b2c0bfe925799aca |
| 출처 메모 | uspto-grants-1998_06 |